These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2791191

  • 1. Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.
    Ueda T, Nakamura T, Kagawa D, Uchida M, Domae N, Sugiyama M, Ueda Y, Sasada M, Uchino H.
    Cancer Chemother Pharmacol; 1989; 24(6):371-5. PubMed ID: 2791191
    [Abstract] [Full Text] [Related]

  • 2. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
    Ueda T, Kamiya K, Urasaki Y, Wataya S, Kawai Y, Tsutani H, Sugiyama M, Nakamura T.
    Cancer Res; 1994 Jan 01; 54(1):109-13. PubMed ID: 8261429
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.
    Ueda T, Nakamura T, Ando S, Kagawa D, Sasada M, Uchino H, Johno I, Akiyama Y.
    Cancer Res; 1983 Jul 01; 43(7):3412-6. PubMed ID: 6850647
    [Abstract] [Full Text] [Related]

  • 4. Plasma and leukemic cell pharmacokinetics of high-dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute leukemia patients.
    Yoshida T, Kobayashi K, Okabe Y, Okumura H, Matano S, Kanno M, Takeda Y, Ohtake S, Nakamura S, Matuda T.
    J Clin Pharmacol; 1994 Jan 01; 34(1):52-9. PubMed ID: 8132852
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Jan 01; 44(1):172-7. PubMed ID: 6690034
    [Abstract] [Full Text] [Related]

  • 6. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells.
    Tsuruo T, Iida H, Hori K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4484-8. PubMed ID: 7306971
    [Abstract] [Full Text] [Related]

  • 7. Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
    Horber DH, Schott H, Schwendener RA.
    Br J Cancer; 1995 May 01; 71(5):957-62. PubMed ID: 7734320
    [Abstract] [Full Text] [Related]

  • 8. Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine.
    Damon LE, Plunkett W, Linker CA.
    Cancer Res; 1991 Aug 15; 51(16):4141-5. PubMed ID: 1868435
    [Abstract] [Full Text] [Related]

  • 9. Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937.
    Horber DH, Schott H, Schwendener RA.
    Cancer Chemother Pharmacol; 1995 Aug 15; 36(6):483-92. PubMed ID: 7554040
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y, Kusumoto T, Sakaguchi Y, Kusumoto H, Anai H, Sugimachi K.
    Anticancer Res; 1989 Aug 15; 9(1):41-4. PubMed ID: 2705754
    [Abstract] [Full Text] [Related]

  • 11. Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.
    Ohno R, Kimura K, Ota K, Miura Y, Hoshino A, Hattori K, Hirano M, Ito M, Maekawa T, Nakamura T.
    Med Oncol Tumor Pharmacother; 1987 Aug 15; 4(2):67-73. PubMed ID: 3669779
    [Abstract] [Full Text] [Related]

  • 12. [The simultaneous determination of Ara-U and Ara-C, urinary metabolites of N4-behenoyl-1-beta-D-arabinofuranosylcytosine by mass fragmentography (author's transl)].
    Makino Y, Matsubara Y, Watanabe K, Hirobe M.
    Yakugaku Zasshi; 1982 Jan 15; 102(1):49-55. PubMed ID: 7086638
    [No Abstract] [Full Text] [Related]

  • 13. Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study.
    Kreis W, Budman DR, Chan K, Allen SL, Schulman P, Lichtman S, Weiselberg L, Schuster M, Freeman J, Akerman S.
    Leukemia; 1991 Nov 15; 5(11):991-8. PubMed ID: 1961042
    [Abstract] [Full Text] [Related]

  • 14. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J, Kataoka T, Tsukagoshi S, Sakurai Y, Shibukawa M, Kobayashi H.
    Cancer Res; 1981 Jun 15; 41(6):2501-6. PubMed ID: 7237444
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology studies of 1-beta-D-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug.
    Avramis VI, Weinberg KI, Sato JK, Lenarsky C, Willoughby ML, Coates TD, Ozkaynak MF, Parkman R.
    Cancer Res; 1989 Jan 01; 49(1):241-7. PubMed ID: 2908850
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative.
    Schleyer E, Braess J, Ramsauer B, Unterhalt M, Kaufmann C, Wilde S, Schüssler M, Hiddemann W.
    Leukemia; 1995 Jun 01; 9(6):1085-90. PubMed ID: 7596174
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B, Capizzi RL, Kute TE, Morgan T, Dimling J.
    Cancer Res; 1989 Jun 15; 49(12):3259-66. PubMed ID: 2720678
    [Abstract] [Full Text] [Related]

  • 18. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO, Plunkett W, Dixon DO.
    Cancer Res; 1985 Nov 15; 45(11 Pt 2):5952-7. PubMed ID: 4053067
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Yamada K, Kawashima K, Kato Y, Morishima Y, Tanimoto M, Ohno R.
    Recent Results Cancer Res; 1980 Nov 15; 70():219-29. PubMed ID: 6766563
    [Abstract] [Full Text] [Related]

  • 20. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Liliemark JO, Adams TM, Nowak B, Estey E, Kantarjian H, Keating MJ.
    Cancer Res; 1987 Jun 01; 47(11):3005-11. PubMed ID: 3471322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.